100 years of Bacillus Calmette-Guérin immunotherapy: from cattle to COVID-19

Bacillus Calmette-Guérin (BCG) is the most widely used vaccine worldwide and has been used to prevent tuberculosis for a century. BCG also stimulates an anti-tumour immune response, which urologists have harnessed for the treatment of non-muscle-invasive bladder cancer. A growing body of evidence in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature reviews. Urology Jg. 18; H. 10; S. 611 - 622
Hauptverfasser: Lobo, Niyati, Brooks, Nathan A, Zlotta, Alexandre R, Cirillo, Jeffrey D, Boorjian, Stephen, Black, Peter C, Meeks, Joshua J, Bivalacqua, Trinity J, Gontero, Paolo, Steinberg, Gary D, McConkey, David, Babjuk, Marko, Alfred Witjes, J, Kamat, Ashish M
Format: Journal Article
Sprache:Englisch
Veröffentlicht: England Nature Publishing Group 01.10.2021
Schlagworte:
ISSN:1759-4812, 1759-4820, 1759-4820
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Bacillus Calmette-Guérin (BCG) is the most widely used vaccine worldwide and has been used to prevent tuberculosis for a century. BCG also stimulates an anti-tumour immune response, which urologists have harnessed for the treatment of non-muscle-invasive bladder cancer. A growing body of evidence indicates that BCG offers protection against various non-mycobacterial and viral infections. The non-specific effects of BCG occur via the induction of trained immunity and form the basis for the hypothesis that BCG vaccination could be used to protect against the severity of coronavirus disease 2019 (COVID-19). This Perspective article highlights key milestones in the 100-year history of BCG and projects its potential role in the COVID-19 pandemic.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:1759-4812
1759-4820
1759-4820
DOI:10.1038/s41585-021-00481-1